---
category: news
title: "Lantern Pharma Announces Filing of Seven Patent Applications Globally on Novel DNA-Damaging Agent with Anticancer Properties"
excerpt: "Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADRÂ® artificial intelligence (\"A.I.\") platform to transform oncology drug discovery and development today announced that it has filed seven patent applications globally on a novel DNA-damaging agent with anticancer properties."
publishedDateTime: 2021-03-17T12:00:00Z
originalUrl: "https://www.oaoa.com/news/business/lantern-pharma-announces-filing-of-seven-patent-applications-globally-on-novel-dna-damaging-agent-with/article_d3210a98-e8e5-5bbd-80d1-4cdd69fbde3a.html"
webUrl: "https://www.oaoa.com/news/business/lantern-pharma-announces-filing-of-seven-patent-applications-globally-on-novel-dna-damaging-agent-with/article_d3210a98-e8e5-5bbd-80d1-4cdd69fbde3a.html"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Odessa American
  domain: oaoa.com

topics:
  - AI in Healthcare
  - AI

secured: "fLZbBRyr4XygEG0gu/bvdrcZCkITiTGrT8MIxbEOFlr0vfZsz44Upv7mUlgax1e/JnztIRoyOG/do7zGbDpuWUuazh+SKUyv2tIIrQmQUBr7qhwcQ/n3TlwDECJluyma1lfESYHAZDO05hjf4PwwFRAyb3rLKrc3+Ry0HSvKEcYn/cCUdjaQ2UmOYmf1N04bYiaujJQcERH5E/hzrr9HHI43Yp5HsoSwqUSVOaoZufmCybBADQxTDWlfvwVnF5iOfRRmUSfw5xrUUBUxvt01ehWETgXGVWl0vaywVqFZ8FTlCZI2hC8QVqFUMBxGcqCz8SLf4xipX+A0U0a6ia1VFN0Dpiv1HrR2FD35FiMJIfw=;Ym6bJe1X3X3gcnpy9ST7yg=="
---

